Regen Biopharma Inc Asset Turnover Ratio (RGBP), as of third quarter 2026, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Regen Biopharma Inc   (RGBP)
 

Regen Biopharma Inc Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Due to the increase in investments during the third quarter 2026, Regen Biopharma Inc 's asset turnover ratio sequentially decreased to 0.16 in the third quarter (Jun 30 2026), this is lower than usual.

Within sector 37 more businesses have achieved higher asset turnover ratio. While ranking the asset turnover ratio, among all other companies, it is fair to say, that the company's position has deteriorated in the Third Quarter 2026 compared to the preceding quarter from 977 to 1028.

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

RGBP Asset Turnover Ratio (Jun 30 2026)
III. Quarter		 (Mar 31 2026)
II. Quarter		 (Dec 31 2025)
I. Quarter		 (Sep 30 2025)
IV. Quarter		 (Jun 30 2025)
III. Quarter
Y / Y Asset Change 2216.93 % 53.52 % 70.5 % 70.5 % 26.1 %
Y / Y Revenue Change 0 % 0 % 0 % -48.02 % 0 %
Asset Turnover Ratio (TTM) 0.16 0.92 1.01 1.15 1.65
RGBP's Total Ranking # 1028 # 977 # 735 # 313 # 290
Seq. Asset Change 1810.77 % -5.27 % 0 % 28 % 26.61 %
Seq. Revenue Change 0 % 0 % -0.51 % 0.51 % 0 %



Asset Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 38
Healthcare Sector # 151
Overall Market # 1028

Asset Turnover Ratio Statistics
High Average Low
1.76 0.75 0.11
(Mar 31 2025)   (Mar 31 2022)




RGBP Company Profile • Back to RGBP Efficiency Comparisons • Compare RGBP Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Jun 30 2026 Assets at quarter ending Jun 30 2026
Igc Pharma Inc   0.12 $ 1.101  Millions$ 9.293  Millions
China Pharma Holdings Inc  0.11 $ 3.914  Millions$ 34.164  Millions
Pmgc Holdings Inc   0.11 $ 2.579  Millions$ 22.601  Millions
Tonix Pharmaceuticals Holding Corp   0.11 $ 29.102  Millions$ 260.403  Millions
Beam Therapeutics Inc   0.11 $ 156.035  Millions$ 1,414.853  Millions
Scilex Holding Company  0.11 $ 31.608  Millions$ 297.014  Millions
Nektar Therapeutics  0.09 $ 54.589  Millions$ 610.038  Millions
Lipocine Inc   0.08 $ 1.569  Millions$ 20.568  Millions
Catheter Precision Inc   0.07 $ 1.915  Millions$ 28.322  Millions
Metagenomi Therapeutics Inc   0.06 $ 13.561  Millions$ 209.924  Millions
Nurix Therapeutics Inc   0.06 $ 36.766  Millions$ 595.569  Millions
Caribou Biosciences Inc   0.06 $ 10.035  Millions$ 165.531  Millions
Ispecimen inc   0.06 $ 0.466  Millions$ 8.133  Millions
Prophase Labs Inc   0.05 $ 3.150  Millions$ 60.428  Millions
Insight Molecular Diagnostics Inc   0.05 $ 1.670  Millions$ 34.891  Millions
Dar Bioscience Inc   0.05 $ 1.345  Millions$ 28.355  Millions
Nakamoto Inc   0.05 $ 28.962  Millions$ 616.576  Millions
Agape Atp Corporation  0.05 $ 1.152  Millions$ 24.729  Millions
Instil Bio Inc   0.04 $ 8.968  Millions$ 203.358  Millions
Camp4 Therapeutics Corporation  0.04 $ 4.216  Millions$ 100.772  Millions
Vistagen Therapeutics Inc   0.04 $ 2.501  Millions$ 62.393  Millions
Kyntra Bio Inc   0.04 $ 4.617  Millions$ 116.829  Millions
Blue Water Vaccines Inc  0.03 $ 0.646  Millions$ 18.966  Millions
Northwest Biotherapeutics Inc  0.03 $ 2.173  Millions$ 66.973  Millions
Tao Synergies Inc   0.03 $ 0.772  Millions$ 24.086  Millions
Atrium Therapeutics Inc   0.03 $ 35.974  Millions$ 1,166.283  Millions
Co diagnostics Inc   0.03 $ 0.721  Millions$ 26.893  Millions
Dbv Technologies S a   0.02 $ 5.018  Millions$ 223.351  Millions
Fate Therapeutics Inc   0.02 $ 6.491  Millions$ 301.907  Millions
Medicinova Inc   0.02 $ 0.920  Millions$ 44.080  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.